Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response

Br J Pharmacol. 1995 Aug;115(8):1525-31. doi: 10.1111/j.1476-5381.1995.tb16646.x.

Abstract

1. In this paper we have determined the different signalling pathways involved in muscarinic acetylcholine receptor (AChR)-dependent inhibition of contractility in rat isolated atria. 2. Carbachol stimulation of M2 muscarinic AChRs exerts a negative inotropic response, activation of phosphoinositide turnover, stimulation of nitric oxide synthase and increased production of cyclic GMP. 3. Inhibitors of phospholipase C, protein kinase C, calcium/calmodulin, nitric oxide synthase and guanylate cyclase, shifted the dose-response curve of carbachol on contractility to the right. These inhibitors also attenuated the muscarinic receptor-dependent increase in cyclic GMP and activation of nitric oxide synthase. In addition, sodium nitroprusside, isosorbide, or 8-bromo cyclic GMP, induced a negative inotropic effect, increased cyclic GMP and activated nitric oxide synthase. 4. These results suggest that carbachol activation of M2 AChRs, exerts a negative inotropic effect associated with increased production of nitric oxide and cyclic GMP. The mechanism appears to occur secondarily to stimulation of phosphoinositides turnover via phospholipase C activation. This in turn, triggers cascade reactions involving calcium/calmodulin and protein kinase C, leading to activation of nitric oxide synthase and soluble guanylate cyclase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Atropine / pharmacology
  • Binding Sites
  • Carbachol / pharmacology
  • Cyclic GMP / biosynthesis*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology*
  • Heart Atria / drug effects
  • Heart Atria / enzymology
  • Male
  • Myocardial Contraction / drug effects*
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase / metabolism
  • Parasympatholytics / pharmacology*
  • Phosphatidylinositols / metabolism
  • Pirenzepine / analogs & derivatives
  • Pirenzepine / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Muscarinic / drug effects*
  • Receptors, Muscarinic / metabolism
  • Signal Transduction*
  • Type C Phospholipases / metabolism*

Substances

  • Enzyme Inhibitors
  • Parasympatholytics
  • Phosphatidylinositols
  • Receptors, Muscarinic
  • Nitric Oxide
  • Pirenzepine
  • Atropine
  • Carbachol
  • Nitric Oxide Synthase
  • Type C Phospholipases
  • Cyclic GMP
  • otenzepad